Journal of
Clinical Pathology and Forensic Medicine

  • Abbreviation: J. Clin. Pathol. Forensic Med.
  • Language: English
  • ISSN: 2141-2405
  • DOI: 10.5897/JCPFM
  • Start Year: 2010
  • Published Articles: 30

Full Length Research Paper

Prevalent latent adenocarcinoma of the prostate in forensic autopsies

Wei Tian
  • Wei Tian
  • Department of Forensic Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan. 2International Science and Technology Cooperation Base of Geriatric Medicine, North China University of Science and Technology, Tangshan, China.
  • Google Scholar
Motoki Osawa*
  • Motoki Osawa*
  • Department of Forensic Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
  • Google Scholar


  •  Received: 20 April 2015
  •  Accepted: 05 June 2015
  •  Published: 31 July 2015

References

Andrews GS (1949). Latent carcinoma of the prostate. J. Clin. Path. 2(3):197-208.
Crossref
 
Brawn PN, Kuhl D, Speights VO, Johnson CF, Lind M (1995). The incidence of unsuspected metastases from clinically benign prostate glands with latent prostate carcinoma. Arch. Pathol. Lab. Med. 119(8):731-733.
Pubmed
 
Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, Tulinius H (1977). Latent carcinoma of prostate at autopsy in seven areas. Int. J. Cancer. 20(5):680-688.
Crossref
 
Drake MT (2013). Osteoporosis and cancer. Curr. Osteoporos. Rep. 11(3):163-170.
Crossref
 
Gleason DF (1992). Histologic grading of prostate cancer: a perspective. Hum. Pathol. 23:273-279.
Crossref
 
Hsing AW, Tsao L, Devesa SS (2000). International trends and patterns of prostate cancer incidence and mortality. Int. J. Cancer. 85(1):60-67.
Crossref
 
Kido M, Hitosugi M, Ishii K, Kamimura S, Joh K (2015). Latent prostate cancer in Japanese men who die unnatural deaths: A forensic autopsy study. Prostate. 75(9):917-922.
Crossref
 
Leal J, Hamdy F, Wolstenholme J (2014). Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies. Int. J. Urol. 21(8):786-792.
Crossref
 
Levine B, Titus JM, Moore K, Fowler D (2004). Use of prostate specific antigen in the identification of semen in postmortem cases. Am. J. Forensic Med. Pathol. 25(4):288-290.
Crossref
 
Sakr WA, Grignon DJ, Haas GP, Schomer KL, Heilbrun LK, Cassin BJ, Powell J, Montie JA, Pontes JE, Crissman JD (1995). Epidemiology of high grade prostatic intraepithelial neoplasia. Pathol. Res. Pract. 191(9):838-841.
Crossref
 
Siegel R, Ma J, Zou Z, Jemal A (2014). Cancer statistics, 2014. CA. Cancer J. Clin. 64:9-29.
Crossref
 
Takahashi S, Shirai T, Hasegawa R, Imaida K, Ito N (1992). Latent prostatic carcinomas found at autopsy in men over 90 years old. Jpn. J. Clin. Oncol. 22(2):117-121.
Pubmed
 
Tian W, Osawa M, Horiuchi H, Tomita Y (2004). Expression of the prolactin-inducible protein (PIP/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate. Cancer Sci. 95(6):491-495.
Crossref
 
Yatani R, Chigusa I, Akazaki K, Stemmermann GN, Welsh RA, Correa P (1982). Geographic pathology of latent prostatic carcinoma. Int. J. Cancer. 29(6):611-616.
Crossref
 
Zare-Mirzaie A, Balvayeh P, Imamhadi MA, Lotfi M (2012). The frequency of latent prostate carcinoma in autopsies of over 50 years old males, the Iranian experience. Med. J. Islam Repub. Iran. 26(2):73-77.
Pubmed
 
Zhu YP, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ, Shi GH (2009). Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: Data from China and other Asian countries. Asian J. Androl. 11(1):104-108.
Crossref